Survival for patients with metastatic colon cancer underwent cytoreductive colectomy in the era of rapid development of anticancer drugs: A real-world analysis based on updated population dataset of 2004-2018
Objective: Metastatic colon cancer (mCC) poses a great threat to the survival of patients suffering from it. In the past decade, many clinical trials have been carried out to improve the prognosis of patients with mCC. Numerous treatments have emerged, and satisfactory efficacy has been demonstrated...
Saved in:
Main Authors: | Guangran Meng (Author), Shengtao Yang (Author), Feixiang Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peristomal pyoderma gangrenosum in patients who underwent colectomy and colostomy for incurable inflammatory bowel disease
by: Takaharu Ikeda, et al.
Published: (2020) -
CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery
by: Wang Fang, et al.
Published: (2013) -
Colectomy Followed by J-Pouch Reconstruction to Correct Total Colonic Aganglionosis
by: Konrad Reinshagen, et al.
Published: (2022) -
Quaternary and beyond cytoreduction: An updated and expanded analysis
by: Beryl L. Manning-Geist, et al.
Published: (2021) -
A right colonic volvulus requiring extensive colectomy in an infant with trisomy 13
by: Kazuto Suda, et al.
Published: (2015)